Abstract
The Liver Imaging and Reporting Data System (LI-RADS) is a comprehensive system for standardizing the terminology, technique, interpretation, reporting, and data collection of liver imaging with the overarching goal of improving communication, clinical care, education, and research relating to patients at risk for or diagnosed with hepatocellular carcinoma (HCC). In 2018, the American Association for the Study of Liver Diseases (AASLD) integrated LI-RADS into its clinical practice guidance for the imaging-based diagnosis of HCC. The harmonization between the AASLD and LI-RADS diagnostic imaging criteria required minor modifications to the recently released LI-RADS v2017 guidelines, necessitating a LI-RADS v2018 update. This article provides an overview of the key changes included in LI-RADS v2018 as well as a look at the LI-RADS v2018 diagnostic algorithm and criteria, technical recommendations, and management suggestions. Substantive changes in LI-RADS v2018 are the removal of the requirement for visibility on antecedent surveillance ultrasound for LI-RADS 5 (LR-5) categorization of 10-19 mm observations with nonrim arterial phase hyper-enhancement and nonperipheral “washout”, and adoption of the Organ Procurement and Transplantation Network definition of threshold growth (≥ 50% size increase of a mass in ≤ 6 months). Nomenclatural changes in LI-RADS v2018 are the removal of -us and -g as LR-5 qualifiers.
Similar content being viewed by others
References
Torre Lindsey A, et al. (2015) Global cancer statistics, 2012. CA A Cancer J Clin 65(2):87–108
Wong MCS, et al. (2017) International incidence and mortality trends of liver cancer: a global profile. Sci Rep 7:45846
Nishikawa H, Osaki Y (2015) Liver cirrhosis: evaluation, nutritional status, and prognosis. Mediat Inflamm 2015:872152
Ferlay J, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917
Beasley RP, et al. (1981) Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan. The Lancet 318(8256):1129–1133
Dhir M, et al. (2012) Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis. HPB 14(9):635–645
Song DS, Bae SH (2012) Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period. Clin Mol Hepatol 18(3):258–267
Ganeshan D, et al. (2018) Structured reporting in radiology. Acad Radiol 25(1):66–73
European Society of R (2018) ESR paper on structured reporting in radiology. Insights Imaging 9(1):1–7
America RSON (2018) Radiological Society of North America radiology reporting initiative. https://www.rsna.org/Reporting_Initiative.aspx. Accessed 1 July 2018
Enterprise ITH (2018) Management of radiology report templates (MRRT). https://www.ihe.net/uploadedFiles/Documents/Radiology/IHE_RAD_Suppl_MRRT.pdf. Accessed 28 July 2018
American College of Radiology (2017) CT/MRI LI-RADS v2017 core. https://www.acr.org/-/media/ACR/Files/RADS/LI-RADS/LIRADS_2017_Core.pdf
American College of Radiology (2013) LI-RADS v2013.1. https://www.acr.org/-/media/ACR/Files/RADS/LI-RADS/LIRADSv2013.pdf?la=en
American College of Radiology (2014) LI-RADS v2014. https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADS/LI-RADS-v2014
American College of Radiology (2011) LI-RADS Version 1.0. https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADS/LI-RADS1
Grimm LJ, et al. (2015) Interobserver variability between breast imagers using the fifth edition of the BI-RADS MRI Lexicon. AJR 204(5):1120–1124
Mahoney MC, et al. (2012) Positive predictive value of BI-RADS MR imaging. Radiology 264(1):51–58
Barth BK, et al. (2016) Reliability, validity, and reader acceptance of LI-RADS-An in-depth analysis. Acad Radiol 23(9):1145–1153
American College of Radiology (2018) CT/MRI LI-RADS v2018 core
Chernyak V, et al. (2018) LI-RADS((R)) ancillary features on CT and MRI. Abdom Radiol 43(1):82–100
Vilgrain V, et al. (1999) Hepatic nodules in Budd-Chiari syndrome: imaging features. Radiology 210(2):443–450
Santillan C, Chernyak V, Sirlin C (2018) LI-RADS categories: concepts, definitions, and criteria. Abdom Radiol 43(1):101–110
van der Pol CB, LC, Bashir MR, Sirlin CB, McGrath TA, Salameh JP, Singal AG, Tang A, Fowler K, Costa A, McInnes MDF (2018) What is the percentage of hepatocellular carcinoma and overall malignancy within each LI-RADS category? A systematic review. ILCA 2018: 12th annual conference of the international liver cancer association
Fowler KJ, et al. (2018) LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma. Abdom Radiol 43(1):149–157
Kambadakone AR, et al. (2018) LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound. Abdom Radiol 43(1):56–74
Sun H, Song T (2015) Hepatocellular carcinoma: advances in diagnostic imaging. Drug Discov Ther 9(5):310–318
Choi J-Y, Lee J-M, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology 273(1):30–50
Marin D, et al. (2015) CT appearance of hepatocellular carcinoma after locoregional treatments: a comprehensive review. Gastroenterol Res Pract 2015:670965
Kielar A, et al. (2018) Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm. Abdom Radiol 43(1):218–230
Nakamura Y, et al. (2011) Clinical significance of the transitional phase at gadoxetate disodium-enhanced hepatic MRI for the diagnosis of hepatocellular carcinoma: preliminary results. J Comput Assist Tomogr 35(6):723–727
Santillan C, et al. (2018) LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents. Abdom Radiol 43(1):75–81
Wald C, et al. (2013) New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology 266(2):376–382
Heimbach JK, et al. (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67(1):358–380
Acknowledgements
The author(s) are military service members. This work was prepared as part of official duties. Title 17 U.S.C. 105 provides that ‘Copyright protection under this title is not available for any work of the United States Government.’
Disclaimer
The views expressed in this presentation are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense or the United States Government.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Elsayes, K.M., Kielar, A.Z., Elmohr, M.M. et al. White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI. Abdom Radiol 43, 2625–2642 (2018). https://doi.org/10.1007/s00261-018-1744-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-018-1744-4